EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation

Xun-Hong Cao, Ze-Ying Fan, Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Xiang-Yu Zhao iD

Journal of Translational Medicine · 06.03.2024 · 22 (1)

DOI: 10.1186/s12967-024-05042-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Medicine, online erschienen am 06.03.2024. Verfasst von Xun-Hong Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing Ke…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science, Technology& Innovation Project of Xiongan New area, Peking University People's Hospital Research and Development Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for hematological malignancies. However, viral infections, particularly EBV infection, frequently occur following allo-HSCT and can result in multi-tissue and organ damage. Due to the lack of effective antiviral drugs, these infections can even progress to post-transplant lymphoproliferative disorders (PTLD), thereby impacting the prognosis. In light of this, our objective is to develop a prediction model for EBV infection following allo-HSCT.

Methods

A total of 466 patients who underwent haploidentical hematopoietic stem cell transplantation (haplo-HSCT) between September 2019 and December 2020 were included in this study. The patients were divided into a development cohort and a validation cohort based on the timing of their transplantation. Our aim was to develop and validate a grading scale using these cohorts to predict the risk of EBV infection within the first year after haplo-HSCT. Additionally, single-cell RNA sequencing (sc-RNAseq) data from the bone marrow of healthy donors were utilized to assess the impact of age on immune cells and viral infection.

Results

In the multivariate logistic regression model, four predictors were retained: donor age, female-to-male transplant, graft MNC (mononuclear cell) dose, and CD8 dose. Based on these predictors, an EBV reactivation predicting score system was constructed. The scoring system demonstrated good calibration in both the derivation and validation cohorts, as confirmed by the Hosmer–Lemeshow test (p > 0.05). The scoring system also exhibited favorable discriminative ability, as indicated by the C statistics of 0.72 in the derivation cohort and 0.60 in the validation cohort. Furthermore, the clinical efficacy of the scoring system was evaluated using Kaplan–Meier curves based on risk ratings. The results showed significant differences in EBV reactivation rates between different risk groups, with p-values less than 0.001 in both the derivation and validation cohorts, indicating robust clinical utility. The analysis of sc-RNAseq data from the bone marrow of healthy donors revealed that older age had a profound impact on the quantity and quality of immune subsets. Functional enrichment analysis highlighted that older age was associated with a higher risk of infection. Specifically, CD8 + T cells from older individuals showed enrichment in the pathway of “viral carcinogenesis”, while older CD14 + monocytes exhibited enrichment in the pathway of "regulation of viral entry into host cell." These findings suggest that older age may contribute to an increased susceptibility to viral infections, as evidenced by the altered immune profiles observed in the sc-RNAseq data.

Conclusion

Overall, these results demonstrate the development and validation of an effective scoring system for predicting EBV reactivation after haplo-HSCT, and provide insights into the impact of age on immune subsets and viral infection susceptibility based on sc-RNAseq analysis of healthy donors' bone marrow.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationEpstein-Barr Virus InfectionsHumansFemaleMaleAntiviral AgentsCD8-Positive T-LymphocytesCalibration

Stichwörter der Autor:innen

AgeAllo-HSCTEBVImmuneThe elders

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, Chin…

ORCID-Profile: Xiang-Yu Zhao

Förderung

  • National Natural Science Foundation of China
  • Science, Technology& Innovation Project of Xiongan New area
  • Peking University People's Hospital Research and Development Funds
  • Beijing Nova Program
  • Beijing Science and Technology Plan Project
  • Beijing Life Oasis Public Service Center
  • CSH Young Scholars and 3SBio Pharmaceutical joint research project
  • Peking University People’s Hospital Research and Development Funds

Zitieren

APA

Cao, X. H., Fan, Z. Y., Chang, Y. J., Xu, L. P., Zhang, X. H., Huang, X. J., & Zhao, X. Y. (2024). Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-024-05042-9

Vancouver

Cao XH, Fan ZY, Chang YJ, Xu LP, Zhang XH, Huang XJ, et al. Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation. Journal of Translational Medicine. 2024;22(1). doi:10.1186/s12967-024-05042-9

BibTeX
@article{Cao2024,
  author = {Cao, Xun-Hong and Fan, Ze-Ying and Chang, Ying-Jun and Xu, Lan-Ping and Zhang, Xiao-Hui and Huang, Xiao-Jun and Zhao, Xiang-Yu},
  title = {Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation},
  journal = {Journal of Translational Medicine},
  year = {2024},
  volume = {22},
  number = {1},
  doi = {10.1186/s12967-024-05042-9}
}
Kostenlos starten →